Daily biotech intelligence: FDA actions, drug recalls, and recent research.
PERPHENAZINE — Approved Sponsor: ZYDUS PHARMS · Application type: SUPPL · Date: 20250122 · Priority: STANDARD
LEUPROLIDE ACETATE — Approved Sponsor: AMNEAL · Application type: SUPPL · Date: 20260430 · Priority: STANDARD
LEUPROLIDE ACETATE — Approved Sponsor: UBI · Application type: ORIG · Date: 20241017 · Priority: STANDARD
LEUPROLIDE ACETATE — Approved Sponsor: SANDOZ · Application type: SUPPL · Date: 19981118
The Harvard Drug Group LLC [Class II] — 20260429 Product: Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per Reason: Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
B BRAUN MEDICAL INC [Class II] — 20260429 Product: DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18 Reason: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Leading Pharma, LLC [Class II] — 20260429 Product: Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Reason: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Premier Dental Products Co [Class III] — 20260429 Product: Premier, Monsel's, Ferric Subsulfate Solution, 8 mL bottles, Rx only, Manufacturer: Premier Medical Reason: Labeling: Incorrect or Missing Lot and/or Exp Date:The expiration date has an extra digit and is printed as 2709114 instead of the correct 270914 (202
B BRAUN MEDICAL INC [Class II] — 20260429 Product: LACTATED RINGER'S IRRIGATION, 3000 mL bags, Sterile, Ex only, B. Braun Medical Inc., Bethlehem, PA 1 Reason: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Xiaoyu Wu, Yifei Wang, Tsu-Jui Fu · 2026-05-06 · cs.CV · cs.AI
We study outlier tokens in Diffusion Transformers (DiTs) for image generation. Prior work has shown that Vision Transformers (ViTs) can produce a small number of high-norm tokens that attract disproportionate attention while carrying limited local information, but their role in generative models remains underexplored. We show that this phenomenon a
Nicholas Barnfield, Juno Kim, Eshaan Nichani · 2026-05-06 · stat.ML · cs.IT
How many key-value associations can a $d\times d$ linear memory store? We show that the answer depends not only on the $d^2$ degrees of freedom in the memory matrix, but also on the retrieval criterion. In an isotropic Gaussian model for the stored pairs, we show that top-1 retrieval, where every signal must beat its largest distractor, requires th
Wilson Wu, Victor Lecomte, Michael Winer · 2026-05-06 · cs.LG · cond-mat.dis-nn
By far the most common way to estimate an expected loss in machine learning is to draw samples, compute the loss on each one, and take the empirical average. However, sampling is not necessarily optimal. Given an MLP at initialization, we show how to estimate its expected output over Gaussian inputs without running samples through the network at al
Alexander Hsu, Zhaiming Shen, Wenjing Liao · 2026-05-06 · cs.LG · math.NA
Pre-trained transformers are able to learn from examples provided as part of the prompt without any weight updates, a remarkable ability known as in-context learning (ICL). Despite its demonstrated efficacy across various domains, the theoretical understanding of ICL is still developing. Whereas most existing theory has focused on linear models, we
Srikar Kashyap Pulipaka · 2026-05-06 · cs.CL · cs.AI
We present our system for SemEval-2026 Task 9: Multilingual Polarization Detection, a binary classification task spanning 22 languages. Our approach fine-tunes separate Gemma~3 models (12B and 27B parameters) per language using Low-Rank Adaptation (LoRA), augmented with synthetic data generated by a large language model (LLM). We employ three synth
Alper Yıldırım · 2026-05-06 · cs.LG · cs.AI
Transformer architectures have been widely adopted for time series forecasting, yet whether the representational mechanisms that make them powerful in NLP actually engage on time series data remains unexplored. The persistent competitiveness of simple linear models such as DLinear has fueled ongoing debate, but no mechanistic explanation for this p
Kedar Tatwawadi, Parisa Rahimzadeh, Zhanghao Sun · 2026-05-06 · cs.CV · cs.AI
One of the major differentiators unlocked by learned codecs relative to their hard-coded traditional counterparts is their ability to be optimized directly to appeal to the human visual system. Despite this potential, a perceptual yet practical image codec is yet to be proposed. In this work, we aim to close this gap. We conduct a comprehensive s
Freyaa Chawla, Ahan Chawla, Rishi Singh · 2026-05-06 · cs.LG · cs.CY
This paper reflects on a AI research project carried out by a team of high-school and early-undergraduate students under the mentorship of graduate researchers and ably assisted by AI tools. We share our experience in not only on the learning experience for the high school students, but also on how AI tools accelerated the process that enabled the
STAT+: Next-gen Duchenne drug from Entrada disappoints (STAT News) A next-gen Duchenne therapy from Entrada Therapeutics fell short in an early study, as a number of companies race to make improved drugs.
STAT+: Color me skeptical: Drinking gold is not an ALS cure (STAT News) In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water as an ALS treatment.
STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B (STAT News) The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.
Public health experts are worried about the cruise ship hantavirus outbreak, but not for the reason you might think (STAT News) Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ship is ground zero for the next pandemic.
Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came true (STAT News) Legendary cardiologist Eugene Braunwald had two visions for his career. One of them came true.
STAT+: What was lost at the FDA (STAT News) What was lost at the FDA: A year after DOGE’s cuts, six agency staffers describe the work they never thought they’d leave.
STAT+: Oregon hospitals won’t outsource to national physician chain after all (STAT News) Faced with stiff local opposition and a possible loss in court, PeaceHealth drops plan to replace Eugene Emergency Physicians with staffing chain ApolloMD.
Trump administration’s drug strategy is at odds with recent actions on funding, policy (STAT News) The White House nods to medication-assisted treatment and fentanyl test strips, despite recently placing new limits.
STAT+: Administration report on most favored nation drug pricing raises new details — and questions (STAT News) Administration report on most-favored nation drug pricing raises new details — and questions.
STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review (STAT News) Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.
Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline (BioPharma Dive) Centered around a glaucoma therapy in mid-stage testing, the deal is Bayer’s first drug company acquisition in several years and potentially its largest since it purchased AskBio in 2020.
Novo hikes guidance on Wegovy pill’s fast sales start (BioPharma Dive) In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pill.
This briefing is compiled automatically from FDA public APIs (openFDA), arXiv, and industry RSS feeds (STAT News, Fierce Biotech, BioPharma Dive, Nature, Science News). Not investment advice. Verify all data before making any decisions.